Concepedia

Lisa Bodei

LB

Statistics

Publications

120

Citations

11.1K

H-Index

57

Active since

1999

Affiliations

European Institute of Oncology(Current)

Memorial Sloan Kettering Cancer Center

Yale University

Wren Laboratories (United States)

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

Lisa Bodei is an author at European Institute of Oncology specializing in medicine, oncology, and radionuclide therapy.

ORCID

Publications per year

1999–2025

120

Publications

120

The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours

John J. Zaknun, Lisa Bodei, Jan Mueller‐Brand et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2013 · 809 citations · Full text

, , +17

Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors

Lisa Bodei, Mark Kidd, Giovanni Paganelli et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2014 · 466 citations

, , +7

Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factors

Lisa Bodei, Marta Cremonesi, Mahila Ferrari et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2008 · 424 citations

, , +17

Peptide receptor radionuclide therapy with 177Lu-DOTATATE: the IEO phase I-II study

Lisa Bodei, Marta Cremonesi, Chiara Maria Grana et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2011 · 421 citations

, , +14

EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands (177Lu-PSMA-RLT)

Clemens Kratochwil, Wolfgang P. Fendler, Matthias Eiber et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2019 · 383 citations

, , +16

1–5 of 120